Literature DB >> 12177588

Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophrenia.

K Alptekin1, B B Kivircik.   

Abstract

There are very rare cases indicating the effectiveness of the atypical antipsychotics in the treatment of tardive dyskinesia except clozapine. We report three patients with schizophrenia who demonstrated improvement of tardive dyskinesia following treatment with quetiapine; two of them were unable to use clozapine because of intolerable side-effects.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12177588     DOI： 10.1097/00004850-200209000-00006

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN： 0268-1315            Impact factor:   1.659


  4 in total

1.  Antipsychotic-induced movement disorders: evaluation and treatment.

Authors:  Maju Mathews; Sylvia Gratz; Babatunde Adetunji; Vinu George; Manu Mathews; Biju Basil
Journal:  Psychiatry (Edgmont)       Date:  2005-03

Review 2.  Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.

Authors:  Joseph M Pierre
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Late-onset Quetiapine-related Tardive Dyskinesia Side Effects in a Patient with Psychotic Depression.

Authors:  Yi-Cheng Hou; Chien-Han Lai
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-08-12       Impact factor: 2.582

4.  Successful Management of Tardive Dyskinesia with Quetiapine and Clonazepam in a Patient of Schizophrenia with Type 2 Diabetes Mellitus.

Authors:  Satyakam Mohapatra
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-05-31       Impact factor: 2.582
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.